SOUTH SAN FRANCISCO, Calif. & LOS ANGELES & SAN DIEGO–(BUSINESS WIRE)– #DrugPricing–Biocom, the largest life science membership association, representing companies across California and major life science markets, issued the following statement in response to the recent tariffs on patented pharmaceuticals and their ingredients under Section 232 of the Trade Expansion Act. This statement may be attributed to Tim Scott, president and CEO of Biocom: Biocom shares the Administration’s interest in protecting ou
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
